The mode of action of virustomycin A, a novel 18-membered macrolide, on Trichomonas foetus was investigated. The antibiotic inhibited the biosynthesis of RNA, DNA and protein in the organism. The inhibition of RNA biosynthesis was the most severe. Virustomycin A repressed the incorporation of [3H]uridine into both acid-soluble and insoluble fractions, whereas actinomycin D inhibited the incorporation of [3H]uridine into acid-insoluble fraction alone. Furthermore, it was found that virustomycin A interfered with nucleotide formation from uridine and adenosine but not with their transport to the cells. On the other hand, the antibiotic did not inhibit the activities of uridine kinase and uracil phosphoribosyltransferase in a cell-free extract from the organism. These data suggest that the antibiotic interferes with the formation of phosphate donor(s) (possibly ATP-forming system) of the organism. The present paper describes the mode of action of virustomycin A on Trichomonas foetus.
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Materials and Methods
Organism and Media A strain of Trichomonas foetus provided from Merck Sharp & Dohme Res. Labs., U. S. A. was maintained at 37°C in DIAMOND's medium5) supplemented with 10% heat-inactivated calf serum, 100 U/ml of benzylpenicillin and 1.0 mg/ml of streptomycin sulfate, using 48-hour transfers. A 24-hour culture grown in DIAMOND'S medium (without agar) supplemented with 10%, heat-inactivated calf serum was used in the experiments. The number of cells was counted with a hematocytometer.
Antitrichomonal Activity Minimum inhibitory concentration (MIC) and minimum "cidal" concentration (MCC) against the organism were determined in DIAMOND'S medium (without agar) according to the method described by ASAMI et al.6) The MIC was read as the least concentration of drug showing growth below twofold number of inoculated cells (inoculum size, 1 X 104 cells/ml). After the MIC experiment, an aliquot of the drudg-treated culture was transferred into a fresh medium without drug, and incubated at 37 °C for 42 hours. The MCC was read as the least concentration of drug showing no growth in the fresh medium.
Incorporation of Radioactive Precursors into Acid-soluble and Insoluble Fractions in T. foetus A radioactive precursor was added to a growing culture (3 -3.4 x 106 cells/ml) of T. foetus in DIA-MOND's medium (without agar) and the culture was incubated at 37°C forgiven period. The cells were harvested by centrifugation, and washed three times in ice-cold saline at O°C. Then, the cells were resuspended in ice-cold saline and 1 volume of ice-cold 0.6 N perchloric acid (PCA) was added to the suspension. The resulted precipitate (acid-insoluble fraction) was collected on a Toyo membrane filter (type TM-2) and then washed with ice-cold 0.3 N PCA. The filter was dried and the radioactivity was counted by a liquid scintillation spectrometer using a toluene scintillation system (5 g of 2,5-diphenyloxazole and 100 mg of 1,4-bis-[2-methylstyryl]benzene in 1 liter of toluene). An aliquot of the filtrate (acidsoluble fraction) was mixed with ACS II Aqueous Counting Scintillant (Amersham Co.) and the radioactivity was measured with a liquid scintillation spectrometer.
Analysis of Nucleotides in an Acid-soluble Fraction UMP, UDP, UTP, uridine and uracil contained in an acid-soluble fraction were analyzed by paper chromatography using Toyo No. 51A filter paper and iso-butyric acid -CH3COOH -1 N NH4OH (10: 1: 5)7) as a developing solvent. After the development, UV-absorbing spots on the paper were cut off to analyze for radioactivity. Rf values are: UTP 0.14, UDP-glucose 0.16, UDP 0.22, UMP 0.32, uridine 0.54, uracil 0.66.
Preparation of a Cell-free Extract8) Cells were harvested by centrifugation in the late logarithmic phase of growth and washed three times with 1/15 M phosphate buffered saline (pH 7.6). Then, the cells were resuspended in 50 mm TrisHCl (pH 7.6) containing 10 mm 2-mercaptoethanol, broken by sonication (30 seconds, five times) under cooling conditions, and centrifuged at 4°C and 105,000 / g for 1 hour. The supernatant fluid was used as an enzyme preparation for the following assays.
Enzyme Assays', Uridine Kinases: A reaction mixture (200 Id) containing 62.5 mrvt Tris-HCI (pH 7.6), 2.5 mm phosphoglyceric acid, 12.5 mm MgC12, 1 mm ATP, 10 mm 2-mercaptoethanol, 72 nN1 [3H]uridine and 100 µl of enzyme solution was incubated for 30 minutes at 37°C, and the reaction was terminated by adding 0.25 ml of ice-cold 4.0 M PCA. The labeled UMP in the reaction mixture was analyzed by paper chromatography as described above.
Uracil Phosphoribosyltransferase: A reaction mixture (200 til) containing 100 mm Tris-HCI (pH 7.8), 7 mm MgCl2, I mti 5-phosphoribosyl-l-pyrophosphate, 1 Fag of bovine serum albumin, 4 / M [14C]-uracil and 30 Id of enzyme solution was incubated for 30 minutes at 30°C. A suspension (3 ml) of icecold polyethyleneimine cellulose in 1 mm CH,000NH4 was added to the reaction mixture. The cellulose was collected on a Whatman GF/C glass microfiber filter, and washed three times with ice-cold 1 mM CH3000NH4.
The filter was dried and the radioactivity was counted.
Chemicals Virustomycin A was prepared as reported previously1 
Results and Discussion
Antitrichomonal Activity of Virustomycin A against T. foetus
The activity of virustomycin A against Ts foetus was examined by the method of ASAMI et aI. > Table  I shows that the MIC and MCC were almost equivalent to those of metronidazole, which is used as an antitrichomonal agent in the medical field. The MIC (1.6 tag/ml) of virustomycin A is different from that (25 tag/m1) of the previous report'). The difference seems to be due to the use of a different method including a different medium for the MIC determination. Fig. 2 shows the effect of virustomycin A on the growing culture of T. foetus. When virustomycin A was added to the culture in the initial stage, the growth was significantly repressed at the concentration of 0.3 dig/ml, and the cells were lysed at 3.0 teg/ml. When it was added to a logarithmic phase culture, the cells were also lysed at the concentrations of both 0.3 and 3.0 ,e cg/ml. These results indicate that a logarithmic phase culture is more susceptible to the antibiotic than is an initial stage culture just after being inoculated with cells from a stationary phase. [3H]Uracil instead of [3H]uridine was used because the incorporation rate of the former was higher than that of the latter. At 20°C, the incorporation of [3H]uracil into the acid-soluble fraction occurred at an appreciable rate while the rate of incorporation into acid-insoluble fraction was very low. These results indicate that, at this temperature, transport of [3H]uracil and nucleotide formation from [3H]uracil and further phosphorylation of nucleotide continues while RNA synthesis is arrested. Fig. 5 shows that, at 37°C, the labeled nucleotides were transferred from the pool into nucleic acids and that virustomycin A had no effect on the transfer. Table   2 , the formation of UMP, UDP and UTP from uracil or uridine was inhibited by virustomycin A; The inhibition of nucleotide formation from uridine was stronger than that from uracil. The inhibition of the incorporation of adenosine into acid-soluble fraction was also stronger than that of adenine.
In general, formation of nucleoside triphosphates (substrates for RNA polymerase) from uracil and uridine requires uridine kinase, uracil phosphoribosyltransferase and nucleotide-phosphorylating systems. As shown in Table 3 , the activities of uridine kinase and uracil phosphoribosyltransferase in a cell-free extract from the organism were not affected by the antibiotic. Also, since the rates of inhibition of nucleotides (UMP, UDP and UTP) formation shown in Table 3 were almost equivalent each To confirm the above speculation, the site of action of virustomycin A on an ATP-forming system(s) in T. foetus must be determined. Experiments with a cell-free extract from the organism are now in progress. 
